---
title: "Shanghai Medicilon Inc. (688202.SH)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/688202.SH.md"
symbol: "688202.SH"
name: "Shanghai Medicilon Inc."
industry: "Life Sciences Tools and Services"
datetime: "2026-06-10T02:29:08.010Z"
locales:
  - [en](https://longbridge.com/en/quote/688202.SH.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688202.SH.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688202.SH.md)
---

# Shanghai Medicilon Inc. (688202.SH)

## Company Overview

Shanghai Medicilon Inc., a contract research organization, provides drug discovery and development services to pharmaceutical and biotechnology companies in China and internationally. The company operates in Drug Discovery and Pharmaceutical Research, and Preclinical Research segments. It offers medicinal and analytical chemistry; process development; custom and zoom in synthesis; structural, in vitro, and computational biology; protein expression and purification; protein crystallization; and recombinant kinase preparation services, as well as protein target validation, compound activity screening and optimization, raw material and preparation process research, and quality standards and stability research services. The company also provides process route screening, API production process optimization, drug process research and application, pharmacology services, drug safety evaluation, biological analysis, IND filing, and TCM preclinical trial service solutions, such as pharmaceutical research, pharmacodynamics, pharmacokinetics, and toxicology.

| Item | Detail |
|------|--------|
| Industry | Life Sciences Tools and Services |
| Exchange | CN Market |
| Website | [www.medicilon.com.cn](https://www.medicilon.com.cn) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-06-09T04:30:12.000Z

**Overall: C (0.47)**

**Industry**: Life Sciences Tools and Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 18 / 27 |
| Industry Median | B |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 20.59% |  |
| Net Profit YoY | 55.28% |  |
| P/B Ratio | 3.52 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 6911747619.35 |  |
| Revenue | 1263932316.07 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -6.74% | D |
| Profit Margin | -10.92% | D |
| Gross Margin | 26.06% | C |
| Revenue YoY | 20.59% | B |
| Net Profit YoY | 55.28% | B |
| Total Assets YoY | -2.54% | D |
| Net Assets YoY | -7.87% | D |
| Cash Flow Margin | -72.20% | E |
| OCF YoY | 20.59% | B |
| Turnover | 0.45 | C |
| Gearing Ratio | 29.20% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Shanghai Medicilon Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "20.59%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "55.28%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "3.52",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "6911747619.35",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "1263932316.07",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "-6.74%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "-10.92%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "26.06%",
          "rating": "C"
        },
        {
          "name": "Revenue YoY",
          "value": "20.59%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "55.28%",
          "rating": "B"
        },
        {
          "name": "Total Assets YoY",
          "value": "-2.54%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "-7.87%",
          "rating": "D"
        },
        {
          "name": "Cash Flow Margin",
          "value": "-72.20%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "20.59%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "0.45",
          "rating": "C"
        },
        {
          "name": "Gearing Ratio",
          "value": "29.20%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -50.81 | 23/27 | - | - | - |
| PB | 3.57 | 22/27 | 4.47 | 4.14 | 3.69 |
| PS (TTM) | 5.55 | 13/27 | 8.55 | 7.87 | 6.82 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | WuXi AppTec (603259.SH) | A | A | C | A | B | B |
| 02 | Pharmaron (300759.SZ) | B | B | C | B | B | B |
| 03 | Chemexpress (688131.SH) | B | B | C | C | B | B |
| 04 | HitGen (688222.SH) | B | A | D | B | C | B |
| 05 | GEMPHARMATECH (688046.SH) | B | B | D | A | B | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/688202.SH/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/688202.SH/norm.md)
- [Related News](https://longbridge.com/en/quote/688202.SH/news.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**